메뉴 건너뛰기
Annales Pharmaceutiques Francaises
Volumn 66, Issue 4, 2008, Pages 212-215
Contaminated heparins;Les héparines contaminées
Author keywords

Chrondoitin persulfate; Contamination; Heparins; Pharmaceutical chain
Indexed keywords

CHONDROITIN SULFATE; ENOXAPARIN; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;
EID: 58149164624     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2008.07.004     Document Type: Article
Times cited : (5)
References (8)
  • 1
    • 68649108291 scopus 로고    scopus 로고
    • http://www.fda.gov/, accédé le 10 juin 2008.
    • http://www.fda.gov/, accédé le 10 juin 2008.
  • 2
    • 45149118311 scopus 로고    scopus 로고
    • Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
    • [Epub 2008 Apr 23]
    • Guerrini M., Beccati D., Shriver Z., Naggi A., Viswanathan K., Bisio A., et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 26 6 (2008) 669-675 [Epub 2008 Apr 23]
    • (2008) Nat Biotechnol , vol.26 , Issue.6 , pp. 669-675
    • Guerrini, M.1    Beccati, D.2    Shriver, Z.3    Naggi, A.4    Viswanathan, K.5    Bisio, A.6
  • 3
    • 68649095807 scopus 로고    scopus 로고
    • Quels contrôles sur les héparines ?
    • Browaeys D.B. Quels contrôles sur les héparines ?. Recherche 379 (2004) 6063
    • (2004) Recherche , vol.379 , pp. 6063
    • Browaeys, D.B.1
  • 4
    • 0026681184 scopus 로고
    • Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosylaminoglycan
    • Greinacher A., Michels I., Schafer M., Kiefel V., and Mueller Eckhardt C. Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosylaminoglycan. Br J Haematol 81 (1992) 252-254
    • (1992) Br J Haematol , vol.81 , pp. 252-254
    • Greinacher, A.1    Michels, I.2    Schafer, M.3    Kiefel, V.4    Mueller Eckhardt, C.5
  • 5
    • 44849115945 scopus 로고    scopus 로고
    • Contaminated heparin associated with adverse clinical events and activation of the contact system
    • [Epub 2008 Apr 23]
    • Kishimoto T.K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358 23 (Jun 5; 2008) 2457-2467 [Epub 2008 Apr 23]
    • (2008) N Engl J Med , vol.358 , Issue.23 , pp. 2457-2467
    • Kishimoto, T.K.1    Viswanathan, K.2    Ganguly, T.3    Elankumaran, S.4    Smith, S.5    Pelzer, K.6
  • 6
    • 68649113243 scopus 로고    scopus 로고
    • http://agmed.sante.gouv.fr/ ; accédé le 18 juin 2008.
    • http://agmed.sante.gouv.fr/ ; accédé le 18 juin 2008.
  • 7
    • 44349115091 scopus 로고    scopus 로고
    • Analytical chemistry comes to the fore
    • Kemsley J. Analytical chemistry comes to the fore. Chem Eng News 86 18 (2008) 37
    • (2008) Chem Eng News , vol.86 , Issue.18 , pp. 37
    • Kemsley, J.1
  • 8
    • 50649115350 scopus 로고    scopus 로고
    • Pour une stricte qualité des matières premières à usage pharmaceutique
    • Astier A. Pour une stricte qualité des matières premières à usage pharmaceutique. Ann Pharm Fr 2 (2008) 69-70
    • (2008) Ann Pharm Fr , vol.2 , pp. 69-70
    • Astier, A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.